Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Several studies have suggested that non‐alcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease (CVD). The excretion of low‐level albuminuria (LLA) elevates as the prevalence of CVD increases. However, few studies have explored the association between NAFLD and LLA.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>This cross‐sectional study included 31 147 Chinese adults (7664 men and 23 483 women). The "normal" level of albuminuria as determined by the urinary albumin to creatinine ratio (UACR) was below 30 mg/g. LLA was defined as a higher level within the "normal" albuminuria range (5.54 mg/g < LLA≤29.9 mg/g). The participants with NAFLD were defined as having a fatty liver index (FLI) ≥ 60. The FLI was calculated using the Bedogni equation.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>A positive association was found between UACR and FLI through multivariate linear regression analyses (nonstandardized β ± SE: 0.047 ± 0.004, <i>P</i> < 0.001). The logistic regression analyses revealed that NAFLD had adjusted odds ratios (ORs) showing a significant relationship with LLA in models 1‐4 (all subjects: OR, 1.207; 95% CI, 1.098‐1.326; women: OR, 1.43; 95% CI, 1.26‐1.63; all <i>P</i> < 0.001); however, we did not find significant adjusted ORs among the men. In the stratified analyses, the relationship between NAFLD and LLA was significant among postmenopausal women with a body mass index ≥24 but <28 kg/m<sup>2</sup>, fasting plasma glucose≥5.6 but <7.0 mmol/L, or postprandial plasma glucose ≥7.8 but <11.1 mmol/L and those aged below 60 years without moderate‐intensity exercise. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>A noteworthy association between NAFLD and LLA was found among postmenopausal women who had borderline blood glucose values, were overweight and did not engage in moderate‐intensity physical activity.</p></section>

Serum Retinol Binding Protein 4 and Galectin-3 Binding Protein As Novel Markers for Postmenopausal Nonalcoholic Fatty Liver Disease.

Serum Alkaline Phosphatase, a Risk Factor for Non-Alcoholic Fatty Liver, but Only for Women in Their 30s and 40s: Evidence from a Large Cohort Study

Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women.

Retinol-binding Protein-4 and Nonalcoholic Fatty Liver Disease

SERUM C-C MOTIF LIGAND 11/EOTAXIN-1 MAY SERVE AS A CANDIDATE BIOMARKER FOR POSTMENOPAUSAL OSTEOPOROSIS

Serum CTRP3 Level is Inversely Associated with Nonalcoholic Fatty Liver Disease: A 3-Y Longitudinal Study.

Intestinal Microecology And Expressions Of Serum Fibroblast Growth Factors In Women With Postmenopausal Osteoporosis

Serum Proteomic Analysis Revealed Diagnostic Value of Hemoglobin for Nonalcoholic Fatty Liver Disease

Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case–control study

Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional study

Proteomic analysis to identify differentially expressed proteins between subjects with metabolic healthy obesity and non-alcoholic fatty liver disease.

Inverse Relationship Between Serum Osteocalcin Levels and Nonalcoholic Fatty Liver Disease in Postmenopausal Chinese Women with Normal Blood Glucose Levels

Serum Proteome Profiling Reveals Differentially Expressed Proteins Between Subjects with Metabolically Healthy Obesity and Nonalcoholic Fatty Liver Disease.

A study on the role of serum Retinol Binding Protein 4 in nonalcoholic fatty liver disease

The pattern of lipids and lipoproteins during the menopausal transition in Chinese women.

Novel Serum Biomarkers for Noninvasive Diagnosis and Screening of Nonalcoholic Fatty Liver Disease-Related Hepatic Fibrosis.

Association between nonalcoholic fatty liver and increased low‐level albuminuria in postmenopausal women in China: A cross‐sectional study

Associations between serum total, free and bioavailable testosterone and non-alcoholic fatty liver disease in community-dwelling middle-aged and elderly women

Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD

Serum Metabolome Alterations in Patients with Early Nonalcoholic Fatty Liver Disease.